Hyperexcitability to sulphonylurea in MODY3 [2]

Diabetologia

Volumn 41, Issue 5, 1998, Pages 607-608

  Sovik, O ^a   Njolstad, P ^a   Folling, I ^a   Sagen, J ^a   Cockburn, B N ^a   Bell, G I ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCAGON; GLUCOKINASE; NUCLEAR FACTOR I; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; FAMILY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LETTER; MALE; MATURITY ONSET DIABETES MELLITUS; NORWAY; ORAL DRUG ADMINISTRATION; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL;

CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; DRUG HYPERSENSITIVITY; FAMILY HEALTH; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; MALE; MUTATION; NORWAY; NUCLEAR PROTEINS; PEDIGREE; SULFONYLUREA COMPOUNDS; TRANSCRIPTION FACTORS;

EID: 0031956073     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050956     Document Type: Letter

References (6)